Rituximab maintenance therapy of follicular lymphoma in clinical practice
Abstract Standard of care for patients with symptomatic, advanced‐stage follicular lymphoma (FL) is rituximab‐containing chemoimmunotherapy followed by rituximab maintenance. This prospective, multicenter, noninterventional study analyzed how efficacy and safety data from randomized controlled trial...
Main Authors: | Ulrich Dührsen, Stefanie Broszeit‐Luft, Annette Dieing, Andreas Lück, Piotr Porowski, Marcel Reiser, Ulrike Schwinger, Sandra Klawitter, Katja Krumm, Kathleen Jentsch‐Ullrich |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-07-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.1549 |
Similar Items
-
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region
by: Francesco Autore, et al.
Published: (2020-06-01) -
Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial
by: Zinzani Pier, et al.
Published: (2012-10-01) -
An Overview of Lenalidomide in Combination with Rituximab for the Treatment of Adult Patients with Follicular Lymphoma: The Evidence to Date
by: Yilmaz U, et al.
Published: (2021-09-01) -
TREATMENT OF HIV-ASSOCIATED BURKITT LYMPHOMA
by: Giovanni Donadoni, et al.
Published: (2013-08-01) -
Loss of CD20 Expression in Follicular Lymphoma after Program Anti-Tumor Therapy Including Rituximab: Literature Data and Case Report
by: OM Volodina, et al.
Published: (2017-04-01)